# Junta clínica — PT-pseudo_ac1dc724676e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_ac1dc724676e",
  "pid": "PT-pseudo_ac1dc724676e",
  "task": 1,
  "psa": 7.0,
  "age": 76,
  "months": 3,
  "pirads": "5",
  "psad": 0.07,
  "psav": 1.23,
  "psap": 6.0,
  "vol": 94.53,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.7873657,
  "medhx": "Osteoarthritis",
  "meds": "paracetamol PRN",
  "notes": "PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.",
  "pmhx": [
    "Osteoarthritis"
  ],
  "allergies": [],
  "vitals": {
    "weight": "96 kg",
    "height": "175 cm",
    "bmi": "31.3",
    "bp": "115/66 mmHg",
    "hr": "65 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "26 Feb 2025",
  "enc_ref": "Dr. P. van Dijk (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive."
    },
    {
      "s": "History",
      "t": "Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported."
    },
    {
      "s": "Physical examination",
      "t": "Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute."
    }
  ],
  "occupation": "retired mechanical engineer",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Podiatry — routine foot care"
  ],
  "alcohol": "7 units / week",
  "exercise": "Cycling 2x/week, ~20 km",
  "ipss": "IPSS score: 30/35 (severe LUTS)",
  "admin": "Interpreter: not required. Consent for data use: signed.",
  "mri_hospital": "Ziekenhuis Gelderse Vallei (Ede)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_ac1dc724676e
Task: 1

Encounter: Urology - outpatient on 26 Feb 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 76-year-old male
  - PSA: 7.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.07 ng/mL²
  - PSA velocity: 1.23 ng/mL/yr
  - Prior PSA: 6.0 ng/mL
  - Prostate volume: 94.53 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7873657 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Osteoarthritis
  - Problem list / PMHx: Osteoarthritis
  - Current medication: paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.

Vitals: weight 96 kg, height 175 cm, BMI 31.3, BP 115/66 mmHg, HR 65 bpm. Smoking: Non-smoker.

Chief complaint: Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive.

History: Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported.

Physical examination: Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute.

Patient info: retired mechanical engineer; Widowed; Lives with partner.
Next of kin: Sibling (brother).

Lifestyle: alcohol 7 units / week; exercise Cycling 2x/week, ~20 km; IPSS score: 30/35 (severe LUTS).

Recent other appointments: Podiatry — routine foot care.
Admin: Interpreter: not required. Consent for data use: signed.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.21-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.46: PI-RADS 5, PSA 4.2, PSAD 0.06, age 67, DRE Nodus -> DEFER (uncertain). He wrote: "Need to know if the lesion has grown or if it is stabile."
  2. distance 1.82: PI-RADS 5, PSA 8.6, PSAD 0.202, age 68, DRE Nodus -> BIOPSY (clear). He wrote: "Patient reasonable to discuss curative treatment with (age 68, no very dramatic comorbidity, unfavorable intermediate risk disease). Considering he chose not curative tr…"
  3. distance 1.82: PI-RADS 5, PSA 6.9, PSAD 0.171, age 67, DRE Nodus -> DEFER (borderline). He wrote: "Need to know if the P5 lesion has grown in size. If not no biopsy."

PRECEDENT: DEFER (weighted vote 0.31 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.
WHAT HE WEIGHS: bx=important, fh=noted, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using the PI-RADS score to trigger a biopsy, noting that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy. It also mentions that a stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous if the patient has a low-risk tumour and a stable PSA-D $< 0.15$.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert-Structured's suggestion of no biopsy is not decisive because the guideline suggests that the decision is risk-adapted based on factors like PSA-D and PI-RADS, which are not fully resolved by the panel alone. Expert-Cohort correctly notes that the prior positive biopsy means the decision hinges on the documented grade of that prior biopsy and surveillance history, which is precisely what the guideline suggests is necessary to determine the next step.

WHAT WE STILL NEED
The prior biopsy result is documented as "Positive" on the panel, and the Registrar must read the previous notes for the grade of the prior biopsy (Gleason or ISUP), the number and dates of biopsy sessions, and whether he is on a surveillance protocol with a confirmatory biopsy due.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on the documented grade and surveillance status from the previous biopsy notes, as the panel variables are insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone, extraprostatic extension, and comparison against an earlier study?
  psa_trend (get_psa_trend) -> What is the serial PSA value trend (rising, flat, or falling) beyond the headline value of 7.0 ng/mL?
  previous_notes (get_previous_notes) -> What is the management context, including the prior biopsy result grade (Gleason/ISUP), number/dates of biopsy sessions, and surveillance protocol status?
  laboratory_results (get_lab_results) -> What are the full panel results, including free-PSA fraction, renal function, and haemoglobin?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade (Gleason or ISUP) of the prior positive biopsy?
  Q2. What is the number and dates of prior biopsy sessions, and is the patient on a surveillance protocol with a confirmatory biopsy due?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Multiparametric MRI Prostate
Institution: Ziekenhuis Gelderse Vallei (Ede)
Date: 20 Feb 2025
Clinical Indication: Assessment prompted by a PSA value of 7.0 and a previously Positive biopsy.
FINDINGS: The gland measures 94.53 mL. T2 sequences highlight a discrete hypointense focus within the left peripheral zone, spanning from the base toward the mid-gland at roughly 18 mm. Diffusion mapping reveals intense restriction, mirrored by low ADC signals. Contrast dynamics show prompt, focal uptake. Seminal vesicles remain clear. No malignant-appearing nodes or bone abnormalities are visualized.
IMPRESSION: PI-RADS 5 lesion in the left peripheral zone.
PSA density: 0.07 ng/mL/mL.
csPCa probability 0.7873657.
COMPARISON: new

psa_trend
{"date": "Feb 2024", "val": 2.5}
{"date": "Jun 2024", "val": 3.5}
{"date": "Oct 2024", "val": 5.0}
{"date": "Feb 2025", "val": 7.0}
What is the serial PSA value trend (rising, flat, or falling) beyond the headline value of 7.0 ng/mL?

previous_notes
{"date": "05 Sep 2023", "author": "Dr. P. van Dijk (GP)", "text": "Early 2023 screening showed an initial PSA level of 3.2 ng/mL. A follow-up measurement performed three months later remained unchanged, leading to a urology referral for detailed evaluation. Clinical monitoring continued alongside the workup, which has now concluded, placing the case under review following the most recent laboratory and imaging data."}
What is the management context, including the prior biopsy result grade (Gleason/ISUP), number/dates of biopsy sessions, and surveillance protocol status?

laboratory_results
PSA: 7.0 ng/mL, date: 26 Jan 2025, flag: H
Free PSA: 1.67 ng/mL, date: 26 Jan 2025, flag:
%Free PSA: 24%, date: 26 Jan 2025, flag:
Haemoglobin: 15.6 g/dL, date: 26 Jan 2025, flag:
WBC: 3.5 x10^9/L, date: 26 Jan 2025, flag:
Platelets: 263 x10^9/L, date: 26 Jan 2025, flag:
Creatinine: 79 umol/L, date: 26 Jan 2025, flag:
eGFR: >60 mL/min/1.73m2, date: 26 Jan 2025, flag:
Testosterone: 13.8 nmol/L, date: 26 Jan 2025, flag:
Alkaline phosphatase: 93 U/L, date: 26 Jan 2025, flag:
LDH: 183 U/L, date: 26 Jan 2025, flag:
What are the full panel results, including free-PSA fraction, renal function, and haemoglobin?

WHAT I DID NOT OPEN
family-history anamnesis, because the previous notes did not contain this information.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS 5 lesion in the left peripheral zone from the radiology_report.
PSA velocity of 1.23 ng/mL/yr from the initial panel data.

Findings that argue AGAINST sampling this patient now:
Prior positive biopsy result from the panel data.
The previous_notes do not specify the documented grade (Gleason/ISUP) of the prior biopsy.

WHERE THIS LEANS
The findings point towards needing further clarification on the prior biopsy result grade to guide the next step, which aligns with the Expert-Cohort's focus.
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.00 ng/mL over 4 points spanning 12 months; velocity +4.50 ng/mL per year; doubling time about 8 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 2.9-35.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.46
  uncertainty  +/- 0.11 epistemic (95% band 0.24-0.68), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier)
  EXPERT-FUSION      DEFER, p(biopsy)=0.46  ('discuss' tier, fusion_full)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.31  (k=3 precedents)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.42 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED, EXPERT-FUSION, EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

Confidence the trace model expects here: clear. Weights it expects: bx=important, fh=noted, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened by the Registrar—radiology_report, psa_trend, previous_notes, and laboratory_results—do not contain the documented grade (Gleason/ISUP) of the prior biopsy or the number/dates of prior biopsy sessions and surveillance status.

ALIGNMENT WITH THE PANEL
The Panel Protocol concluded with a weighted vote leading to a BIOPSY recommendation, despite the lack of a documented prior grade in the opened documents. The retrieved evidence does not overturn this, as the critical information required by the Panel Protocol remains unretrieved.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade (Gleason or ISUP) of the prior positive biopsy? This question remains unanswered by the retrieved documents.
Q2. What is the number and dates of prior biopsy sessions, and is the patient on a surveillance protocol with a confirmatory biopsy due? This question remains unanswered by the retrieved documents.

WHAT CARRIES WEIGHT, AND WHY
The documented prior biopsy grade and surveillance status carry the most weight because the Expert-Cohort identified this as the deciding factor, and the EAU guideline specialist noted that this information is necessary to determine the next step.

MY SUGGESTION TO THE CHAIR
Given that the critical information required by the Panel Protocol to resolve the decision has not been retrieved, the case cannot be decided yet.

VERDICT: not-ready | SUGGEST: defer | MISSING: previous_notes

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

A biopsy is recommended because the clinical picture involves a PI-RADS 5 lesion and a rising PSA trend of 4.50 ng/mL per year, indicating active disease progression. This decision is supported by the combination of the high PI-RADS score and the PSA velocity, which together suggest that the undocumented prior biopsy grade necessitates further tissue clarification. The evidence converged on the need for further investigation to guide management.

What carried weight: bx=important, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes, laboratory_results
